bioLytical to bring new antigen home tests to European market
by CM Staff
The company will manufacture the tests at their facility in Richmond, B.C.
The iStatis COVID-19 Antigen Home Test Kit Components
RICHMOND — bioLytical Laboratories Inc. will launch iStatis, a COVID-19 antigen home test for which they have also obtained a CE Mark preparing the tests for immediate entry in the European market.
bioLytical says the tests are portable and results should be easy to comprehend without additional equipment.
A statement from the company reads that the tests provide an “industry-leading accuracy of 100 per cent.”
“We are excited to announce the addition of iStatis in Europe with our new COVID-19 rapid antigen home test,” said Rob Mackie, CEO of bioLytical.
“With our new iStatis platform, we can expand our reach and increase access to testing across Europe. With the unpredictable nature of the pandemic, we are proud to offer Europeans a reliable and trusted test that they can take in the comfort and privacy of their own homes.”
bioLytical says it anticipates that the iStatis home test will reduce the workload of medical facilities while providing Europeans with peace of mind.
The company will manufacture the tests at their facility in Richmond, B.C.
- Ontario government announces plans to meet with U.S. trade officials in Washington
- Ontario invests in new measures to protect border crossings from illegal blockades
